Parallax Volatility Advisers’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
0
| – | – | – | 946 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 986 |
|
|
2022
Q4 | – | Sell |
-16,173
| Closed | -$1.72M | – | 1238 |
|
|
2022
Q3 | $1.72M | Buy |
16,173
+2,481
| +18% | +$264K | ﹤0.01% | 311 |
|
|
2022
Q2 | $1.34M | Buy |
13,692
+2,135
| +18% | +$208K | ﹤0.01% | 347 |
|
|
2022
Q1 | $1.08M | Buy |
+11,557
| New | +$1.08M | ﹤0.01% | 382 |
|
|
2021
Q4 | – | Sell |
-20,965
| Closed | -$2.01M | – | 846 |
|
|
2021
Q3 | $2.01M | Buy |
20,965
+17,226
| +461% | +$1.65M | ﹤0.01% | 248 |
|
|
2021
Q2 | $364K | Sell |
3,739
-6,243
| -63% | -$608K | ﹤0.01% | 316 |
|
|
2021
Q1 | $971K | Buy |
9,982
+6,359
| +176% | +$619K | ﹤0.01% | 240 |
|
|
2020
Q4 | $347K | Buy |
3,623
+3,166
| +693% | +$303K | ﹤0.01% | 607 |
|
|
2020
Q3 | $44K | Buy |
+457
| New | +$44K | ﹤0.01% | 1089 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1078 |
|
|
2019
Q4 | – | Sell |
-1
| Closed | – | – | 1027 |
|
|
2019
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1606 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1870 |
|
|
2019
Q1 | – | Sell |
-1,813
| Closed | -$129K | – | 2025 |
|
|
2018
Q4 | $129K | Buy |
+1,813
| New | +$129K | ﹤0.01% | 666 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2000 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 1850 |
|
|
2018
Q1 | – | Sell |
-2,091
| Closed | -$162K | – | 2416 |
|
|
2017
Q4 | $162K | Buy |
+2,091
| New | +$162K | ﹤0.01% | 1373 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 1663 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 1822 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 1431 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 1428 |
|